CD44-3MUT

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCD44-3MUT
Drug Alias NameCD44 hyaluronan binding domain triple-mutant peptide therapeutic (Competence Centre for Cancer Research/Tallinn University)CD44-3MUT
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionVimentin inhibitorsVimentin modulators
TargetsVimentin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryEstonia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTallinn University Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTallinn University Of TechnologyCompetence Centre for Cancer Research Ltd. (CCCR)
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A